Tyrosols and derivatives
- (6)
- (8)
- (3)
- (1)
- (1)
- (9)
- (1)
- (5)
- (5)
- (3)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (7)
- (2)
- (1)
- (7)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (4)
- (2)
- (4)
- (2)
- (4)
- (7)
- (2)
- (2)
- (2)
- (1)
- (2)
- (3)
- (12)
- (1)
- (2)
- (2)
- (4)
- (1)
- (2)
- (1)
- (4)
- (1)
- (1)
- (13)
- (1)
- (2)
- (2)
Filtered Search Results
Chemscene ChemScene | Hydroxytyrosol | 1G | CS-0009107 | 0.98 | 10597-60-1| MFCD01320529 | 154.16
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
ChemScene | Hydroxytyrosol | 1G | CS-0009107 | 0.98 | 10597-60-1| MFCD01320529 | 154.16
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Apexbio Technology LLC VX-702 479543-46-9; 745833-23-2 25mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
VX-702 is a small-molecule inhibitor targeting p38 mitogen-activated protein kinase (MAPK) also known as MAPK14 It is designed to inhibit p38 MAPK thereby regulating cellular responses to cytokine signaling and various stressors VX-702 exerts its biological activity primarily through ATP-competitive inhibition In experimental models VX-702 demonstrates potent inhibition with reported IC50 values ranging from 4 to 20 nM Based on these pharmacological properties VX-702 holds research potential in the study of p38 MAPK-dependent pathways platelet storage lesions and renal excretion mechanisms
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Selleck Chemical LLC ABT 702 dihydrochloride
ABT-702 is a novel potent non-nucleoside Adenosine kinase inhibitor with an IC50 of 1 7 nM It has oral activity in animal models of pain and inflammation
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Apexbio Technology LLC Verbascoside 61276-17-3 100mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Verbascoside (CAS 61276-17-3) is a small-molecule inhibitor targeting protein kinase C (PKC) and the NF- B signaling pathway It is designed to modulate these pathways thereby regulating signal transduction and transcriptional activity in cellular responses Verbascoside exerts its biological activity primarily through the inhibition of PKC and suppression of NF- B DNA-binding activation In cell-based studies Verbascoside demonstrates inhibitory activity with an IC50 value of approximately 4 8 M in RANKL-treated RAW264 7 cells and bone marrow macrophages (BMMs) Based on these pharmacological properties Verbascoside holds research potential in the investigation of PKC/NF- B-mediated signaling osteoclastogenesis and related cell signaling mechanisms
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC 6-[(aminocarbonyl)(2,6-difluorophenyl)amino]-2-(2,4-difluorophenyl)-3-pyridinecarboxamide | 745833-23-2 | MFCD11616590 | >98.0% | 404.32 | C19H12F4N4O2 | 200 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
VX-702 is a research-grade small-molecule inhibitor selective for p38α mitogen-activated protein kinase (MAPK). It exhibits approximately 14-fold higher potency for p38α versus p38β and has demonstrated both in vitro and in vivo activity in preclinical inflammatory models. The compound is supplied as a high-purity material suitable for biochemical, cellular, and pharmacology studies.
- Selective p38α MAPK inhibition with approximately 14-fold selectivity versus p38β.
- Potent in vitro activity with reported IC50 values in the ~4-20 nM range.
- Reduces proinflammatory cytokine production (IL-6, IL-1β, TNFα) in dose-dependent studies.
- Documented in vivo pharmacokinetics, including a reported half-life of 16-20 hours.
- Supplied at high purity (>98%).
- Soluble in DMSO at ≥42 mg/mL for assay preparation.
- Intended for research use only.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Metoprolol tartrate United States Pharmacopeia (USP) Reference Standard | 56392-17-7 | MFCD00056257 | 200MG
Metoprolol tartrate United States Pharmacopeia (USP) Reference Standard | Mol Wt: 684.81 | 56392-17-7 | MFCD00056257 | 200MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Indofine Chemical Liquiritigenin With H, 20 Mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
LIQUIRITIGENIN with HPLC, Flavonoid & Coumarins, 578-86-9, 98.5% by HPLC, 10 mg
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules ChemScene / 246-Tribromophenyl methacrylate / 1g / 625603901 / CS-0179372 / 0.000 / 37721-71-4 / MFCD00078329 / 398.876 / C10H7Br3O2
ChemScene / 246-Tribromophenyl methacrylate / 1g / 625603901 / CS-0179372 / 0.000 / 37721-71-4 / MFCD00078329 / 398.876 / C10H7Br3O2
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Betaxolol hydrochloride, Tocris Bioscience™
CAS: 63659-19-8 Molecular Formula: C18H30ClNO3 Molecular Weight (g/mol): 343.892 InChI Key: CHDPSNLJFOQTRK-UHFFFAOYSA-N Synonym: betaxolol hydrochloride,betaxolol hcl,betoptima,kerlone,betoptic,kerlon,lokren,betaxolo hydrochloride,betoptic s PubChem CID: 107952 ChEBI: CHEBI:643228 IUPAC Name: 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride SMILES: CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl
| PubChem CID | 107952 |
|---|---|
| CAS | 63659-19-8 |
| Molecular Weight (g/mol) | 343.892 |
| ChEBI | CHEBI:643228 |
| SMILES | CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl |
| Synonym | betaxolol hydrochloride,betaxolol hcl,betoptima,kerlone,betoptic,kerlon,lokren,betaxolo hydrochloride,betoptic s |
| IUPAC Name | 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride |
| InChI Key | CHDPSNLJFOQTRK-UHFFFAOYSA-N |
| Molecular Formula | C18H30ClNO3 |
CAYMAN CHEMICAL VERBASCOSIDE 25MG
NC3137376 VERBASCOSIDE 25MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More